Anitha S. John
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anitha S. John has a total of 324 co-authors. Here are the top co-authors by number of shared publications:
Ruth Phillippi
Division of Cardiology, Children's National Hospital, 111 Michigan Ave NW, WW 3rd Floor, Washington, DC, 20008, USA
6 shared publicationsMindi Messmer
Division of Cardiology Children's National Hospital Washington District of Columbia USA
5 shared publicationsScott Leezer
CURA Strategies
5 shared publicationsCarole A. Warnes
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
4 shared publicationsAnita Mathews
Division of Cardiology, Children's National Hospital, 111 Michigan Ave NW, WW 3rd Floor, Washington, DC, 20008, USA
3 shared publicationsDavid J. Driscoll
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
3 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in BMC Medical Education
Striving for success: essential skills for women in academic medicine
- 7 October 2026
- Published by Springer Nature in BMC Medical Education
Open AccessStriving for success: essential skills for women in academic medicine
- 15 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- p. e046919
Associations Between Socioeconomic Status and Adult Congenital Heart Disease Mortality in the United States: Insights From the Global Burden of Disease Study
Background: The GBD (Global Burden of Disease) study provides a unique opportunity to better understand the socioeconomic and geographical drivers of clinical outcomes and mortality in adult congenital heart disease (ACHD) in the United States. Methods: We performed a secondary data analysis using a population‐based observational study design that studied state specific data on mortality and disability‐adjusted life years from 1990 to 2021 for patients with ACHD aged 20 years and older in the United States. These data were acquired from the GBD study. We subsequently correlated these data with median household income and percentage of uninsured people in each state by using the US census bureau poverty and income data. Results: In 2021, the GBD study identified 292 624 (95% CI, 258 956–342 906) adults ≥20 years with CHD living in the United States with 1074 (95% CI, 964–1331) ACHD related deaths and 62 244 (95% CI, 51 820–76 301) disability‐adjusted life years. The state with the highest mortality and disability‐adjusted life years (West Virginia) also has one of the lowest median household incomes ($51 122). States with lower ACHD related mortality have higher median household incomes ( r 2 =0.62, P < 0.001). There is a lower correlation between mortality and the percentage of patients uninsured in each state ( r 2 =0.14, P =0.0068). Conclusions: The GBD study provides unique insight into ACHD mortality and disability in the United States. Although mortality and disability rates have decreased from 1990 to 2021, patients with ACHD living in states with lower median household income and higher percentage of uninsured people have higher rates of mortality and disability. Ensuring adequate access to specialized care is warranted for this population.
- 15 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- p. e046919
Associations Between Socioeconomic Status and Adult Congenital Heart Disease Mortality in the United States: Insights From the Global Burden of Disease Study
Background: The GBD (Global Burden of Disease) study provides a unique opportunity to better understand the socioeconomic and geographical drivers of clinical outcomes and mortality in adult congenital heart disease (ACHD) in the United States. Methods: We performed a secondary data analysis using a population‐based observational study design that studied state specific data on mortality and disability‐adjusted life years from 1990 to 2021 for patients with ACHD aged 20 years and older in the United States. These data were acquired from the GBD study. We subsequently correlated these data with median household income and percentage of uninsured people in each state by using the US census bureau poverty and income data. Results: In 2021, the GBD study identified 292 624 (95% CI, 258 956–342 906) adults ≥20 years with CHD living in the United States with 1074 (95% CI, 964–1331) ACHD related deaths and 62 244 (95% CI, 51 820–76 301) disability‐adjusted life years. The state with the highest mortality and disability‐adjusted life years (West Virginia) also has one of the lowest median household incomes ($51 122). States with lower ACHD related mortality have higher median household incomes ( r 2 =0.62, P < 0.001). There is a lower correlation between mortality and the percentage of patients uninsured in each state ( r 2 =0.14, P =0.0068). Conclusions: The GBD study provides unique insight into ACHD mortality and disability in the United States. Although mortality and disability rates have decreased from 1990 to 2021, patients with ACHD living in states with lower median household income and higher percentage of uninsured people have higher rates of mortality and disability. Ensuring adequate access to specialized care is warranted for this population.
- 17 June 2026
- Published by Springer Nature in Pediatric Cardiology
Design and Implementation of My Health, My Heart: A Pilot Healthcare Transition Program for Adolescents with Congenital Heart Disease
Effective healthcare transition for congenital heart disease (CHD) patients to adult-centered care remains a significant challenge. Virtual, family-centered transition programs incorporating individualized goal setting may improve readiness. My Health, My Heart is a 12-month virtual, family centric transition program for patients (12-22 years) with CHD. It includes a social work assessment, individualized goal setting, and sessions focused on medical knowledge, care coordination, and mental health. Validated assessments (transition readiness, health knowledge, PedsQL 4.0, PROMIS anxiety and depression, and parental PSS) were delivered at baseline and completion. Primary outcome was feasibility (enrollment, retention, and barriers); secondary outcomes included changes in transition readiness, medical knowledge, and quality of life. A total of 68 participants (median age 16[13.75-18], 38% F] enrolled, with 41 (60%, median age 16[13-18], 39% F) patients completing both goals. Attrition was highest (37%) from completion of initial surveys to the first goal. Participants reported improvements in confidence managing heart health (median score 6.5[4.25-8] to 8[6-9]) and transition readiness (median score 5[4-8] to 7[5-9]). Quality-of-life scores increased significantly (PedsQL total: 79.4 ± 15.3 → 84.4 ± 15.7, p = 0.006). Among completers, 80% of participants and 90% of caregivers reported being very or extremely satisfied. Qualitative feedback identified ongoing needs in mental health support, practical life skills, and peer connection. The My Health, My Heart telemedicine transition program is feasible and suggests early improvements in quality of life and transition readiness, underscoring the importance of individualized support and caregiver engagement.
- 17 June 2026
- Published by Springer Nature in Pediatric Cardiology
Design and Implementation of My Health, My Heart: A Pilot Healthcare Transition Program for Adolescents with Congenital Heart Disease
Effective healthcare transition for congenital heart disease (CHD) patients to adult-centered care remains a significant challenge. Virtual, family-centered transition programs incorporating individualized goal setting may improve readiness. My Health, My Heart is a 12-month virtual, family centric transition program for patients (12-22 years) with CHD. It includes a social work assessment, individualized goal setting, and sessions focused on medical knowledge, care coordination, and mental health. Validated assessments (transition readiness, health knowledge, PedsQL 4.0, PROMIS anxiety and depression, and parental PSS) were delivered at baseline and completion. Primary outcome was feasibility (enrollment, retention, and barriers); secondary outcomes included changes in transition readiness, medical knowledge, and quality of life. A total of 68 participants (median age 16[13.75-18], 38% F] enrolled, with 41 (60%, median age 16[13-18], 39% F) patients completing both goals. Attrition was highest (37%) from completion of initial surveys to the first goal. Participants reported improvements in confidence managing heart health (median score 6.5[4.25-8] to 8[6-9]) and transition readiness (median score 5[4-8] to 7[5-9]). Quality-of-life scores increased significantly (PedsQL total: 79.4 ± 15.3 → 84.4 ± 15.7, p = 0.006). Among completers, 80% of participants and 90% of caregivers reported being very or extremely satisfied. Qualitative feedback identified ongoing needs in mental health support, practical life skills, and peer connection. The My Health, My Heart telemedicine transition program is feasible and suggests early improvements in quality of life and transition readiness, underscoring the importance of individualized support and caregiver engagement.
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e046867
From Insight to Action: A National Patient‐Centered Strategic Framework for Improving Reproductive Health Outcomes in Individuals With Congenital Heart Disease
Background: An increasing number of patients with congenital heart disease (CHD) are pursuing pregnancy with the potential for cardiovascular complications. This study aimed to establish patient‐centered national research and care priorities to improve pregnancy‐related outcomes for individuals with CHD. Methods: This mixed‐methods study used a modified Stakeholder Engagement in Question Development methodology to systematically identify patient‐centered priorities. Key activities included consortium engagement (phase 1), patient and provider questionnaires (phase 2), and an in‐person facilitated meeting to explore survey results and follow‐up virtual focus groups (phase 3). Reflexive thematic analysis was used to synthesize short‐ and long‐term research priorities (phase 4). Results: Three overarching goals emerged: (1) improving access to specialized CHD, cardio‐obstetrics, and mental health care; (2) improving quality and consistency in clinical care; and (3) increasing patient and community engagement. These goals were then expanded into 5 central themes: (1) communication within the health care setting; (2) community engagement; (3) ancillary clinical support; (4) integration of patient‐reported outcomes; and (5) implementation, education, and knowledge mobilization. Short‐term (1–5‐year) goals included expanded telemedicine use, best practice recommendations for multidisciplinary care coordination, and targeted educational resources. Long‐term (5–10‐year) goals included expansion of adult CHD and cardio‐obstetrics programs, integration of mental health services, and advocacy to improve insurance coverage. Conclusions: The consortium provided a national, community‐driven prioritization that highlights actionable pathways to improve pregnancy outcomes for people with CHD. Sustained engagement with patients and community partners is essential to achieving durable improvements across cardio‐obstetric care, education, research, and mental health.
- 17 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (6) , e046867
Open AccessFrom Insight to Action: A National Patient‐Centered Strategic Framework for Improving Reproductive Health Outcomes in Individuals With Congenital Heart Disease
Background: An increasing number of patients with congenital heart disease (CHD) are pursuing pregnancy with the potential for cardiovascular complications. This study aimed to establish patient‐centered national research and care priorities to improve pregnancy‐related outcomes for individuals with CHD. Methods: This mixed‐methods study used a modified Stakeholder Engagement in Question Development methodology to systematically identify patient‐centered priorities. Key activities included consortium engagement (phase 1), patient and provider questionnaires (phase 2), and an in‐person facilitated meeting to explore survey results and follow‐up virtual focus groups (phase 3). Reflexive thematic analysis was used to synthesize short‐ and long‐term research priorities (phase 4). Results: Three overarching goals emerged: (1) improving access to specialized CHD, cardio‐obstetrics, and mental health care; (2) improving quality and consistency in clinical care; and (3) increasing patient and community engagement. These goals were then expanded into 5 central themes: (1) communication within the health care setting; (2) community engagement; (3) ancillary clinical support; (4) integration of patient‐reported outcomes; and (5) implementation, education, and knowledge mobilization. Short‐term (1–5‐year) goals included expanded telemedicine use, best practice recommendations for multidisciplinary care coordination, and targeted educational resources. Long‐term (5–10‐year) goals included expansion of adult CHD and cardio‐obstetrics programs, integration of mental health services, and advocacy to improve insurance coverage. Conclusions: The consortium provided a national, community‐driven prioritization that highlights actionable pathways to improve pregnancy outcomes for people with CHD. Sustained engagement with patients and community partners is essential to achieving durable improvements across cardio‐obstetric care, education, research, and mental health.
- Open Access
- 8 January 2026
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (3S) , S196-S204
The CHI-RON Study
Background: The Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult-Centered Care (CHI-RON) study is a unique collaboration between the PCORnet and Congenital Heart Initiative (CHI), the first patient powered registry for adult congenital heart disease (ACHD) patients. The CHI-RON study examines the effects of gaps in recommended care in ACHD. Objective: Recruitment of racially diverse, younger, out-of-care, and male participants has been challenging in ACHD studies. Our goal was to design patient engagement and recruitment strategies to improve representation. Research Design: Launched in December 2020, patients from any location can self-enroll in the CHI registry, while the CHI-RON study (5/2022 – 10/2023) recruited ACHD patients at 12 sites participating in PCORnet. CHI-RON Recruitment methodology included a patient partner engagement toolkit and a recruitment algorithm using the PCORnet ® Common Data Model designed specifically to improve diversity and reduce self-enrollment biases in comparison to the CHI registry. Subjects: ACHD patients, age 18 years or older, with the ability to complete PROs independently. Measures: Demographic/Recruitment Statistics for study participants and Patient Engagement in Research Scale (PEIRS-22) for the study team partners. Results: As of October 2023, a total of 2652 participants were recruited through CHI-RON recruitment methodology while 1326 were self-enrolled in the CHI. CHI-RON recruitment methodologies have increased representation when compared with self-enrolled CHI participants in terms of ethnicity (10.9% vs. 7.4% Hispanic, P P P P P <0.001). Most study team patient partners (n=12, 86%) reported a very to extremely high degree of engagement (PEIRS-22 average score 101.6), especially in the subdomains of contributions, support, feeling valued, and benefits. Conclusions: Patient engagement and novel recruitment strategies are critical to improving the inclusion of under-represented populations in clinical research and ensuring alignment with the needs of ACHD patients.
- 8 January 2026
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (3S) , S196-S204
Open AccessThe CHI-RON Study
Background: The Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult-Centered Care (CHI-RON) study is a unique collaboration between the PCORnet and Congenital Heart Initiative (CHI), the first patient powered registry for adult congenital heart disease (ACHD) patients. The CHI-RON study examines the effects of gaps in recommended care in ACHD. Objective: Recruitment of racially diverse, younger, out-of-care, and male participants has been challenging in ACHD studies. Our goal was to design patient engagement and recruitment strategies to improve representation. Research Design: Launched in December 2020, patients from any location can self-enroll in the CHI registry, while the CHI-RON study (5/2022 – 10/2023) recruited ACHD patients at 12 sites participating in PCORnet. CHI-RON Recruitment methodology included a patient partner engagement toolkit and a recruitment algorithm using the PCORnet ® Common Data Model designed specifically to improve diversity and reduce self-enrollment biases in comparison to the CHI registry. Subjects: ACHD patients, age 18 years or older, with the ability to complete PROs independently. Measures: Demographic/Recruitment Statistics for study participants and Patient Engagement in Research Scale (PEIRS-22) for the study team partners. Results: As of October 2023, a total of 2652 participants were recruited through CHI-RON recruitment methodology while 1326 were self-enrolled in the CHI. CHI-RON recruitment methodologies have increased representation when compared with self-enrolled CHI participants in terms of ethnicity (10.9% vs. 7.4% Hispanic, P P P P P <0.001). Most study team patient partners (n=12, 86%) reported a very to extremely high degree of engagement (PEIRS-22 average score 101.6), especially in the subdomains of contributions, support, feeling valued, and benefits. Conclusions: Patient engagement and novel recruitment strategies are critical to improving the inclusion of under-represented populations in clinical research and ensuring alignment with the needs of ACHD patients.
- Open Access
Prioritizing patient‐centered research in adult congenital heart disease and pregnancy: Findings from Phase 3 of a multiphase national initiative
Background: Despite advancements in care, pregnant individuals with congenital heart disease (CHD) face disproportionately high risks. Objectives: To address these challenges, a national consortium was established to improve maternal outcomes in CHD through multidisciplinary collaboration and patient engagement. Study design: As part of a 2.5‐year multi‐phase consortium initiative, an in‐person research summit followed by three virtual focus groups (Project PHASE 3) was conducted with patients, clinicians, researchers, advocates, and policy representatives. Qualitative data were collected, and reflexive thematic analysis was performed to identify shared priorities. Results: A total of 48 individuals participated in the in‐person meeting, including 18 patients (83% female; 11% Black/African American, 17% Asian, 11% Hispanic, 61% White) and 30 clinicians/researchers. An additional 19 patients (100% female; 32% rural/non‐urban; 16% Black/African American, 10% Hispanic, 74% White) participated in virtual focus groups. Key priorities identified included improved patient–healthcare provider communication, expanded access to multidisciplinary and adult CHD‐specialized care, and greater inclusion of patient voices in reproductive planning and research. Focus groups underscored racial disparities in care, limited CHD education for patients of color, and the need for culturally tailored resources. Participants emphasized the importance of representative research cohorts, integration of genetic counseling, and dissemination of research in accessible, plain‐language formats. Conclusions: Findings demonstrate the value of integrating patient expertise and partnership in shaping cardio‐obstetric research, care models, and education. Addressing maternal health concerns in CHD research requires both structural changes and community‐driven, inclusive research strategies.
Open AccessPrioritizing patient‐centered research in adult congenital heart disease and pregnancy: Findings from Phase 3 of a multiphase national initiative
Background: Despite advancements in care, pregnant individuals with congenital heart disease (CHD) face disproportionately high risks. Objectives: To address these challenges, a national consortium was established to improve maternal outcomes in CHD through multidisciplinary collaboration and patient engagement. Study design: As part of a 2.5‐year multi‐phase consortium initiative, an in‐person research summit followed by three virtual focus groups (Project PHASE 3) was conducted with patients, clinicians, researchers, advocates, and policy representatives. Qualitative data were collected, and reflexive thematic analysis was performed to identify shared priorities. Results: A total of 48 individuals participated in the in‐person meeting, including 18 patients (83% female; 11% Black/African American, 17% Asian, 11% Hispanic, 61% White) and 30 clinicians/researchers. An additional 19 patients (100% female; 32% rural/non‐urban; 16% Black/African American, 10% Hispanic, 74% White) participated in virtual focus groups. Key priorities identified included improved patient–healthcare provider communication, expanded access to multidisciplinary and adult CHD‐specialized care, and greater inclusion of patient voices in reproductive planning and research. Focus groups underscored racial disparities in care, limited CHD education for patients of color, and the need for culturally tailored resources. Participants emphasized the importance of representative research cohorts, integration of genetic counseling, and dissemination of research in accessible, plain‐language formats. Conclusions: Findings demonstrate the value of integrating patient expertise and partnership in shaping cardio‐obstetric research, care models, and education. Addressing maternal health concerns in CHD research requires both structural changes and community‐driven, inclusive research strategies.
Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience
Background: Cardiac resynchronisation therapy (CRT) is a key treatment for heart failure (HF) in acquired heart disease, but its benefits in adults with congenital heart disease and a systemic right ventricle (sRV) remain unclear. This study aimed to assess whether CRT improves outcomes in patients with sRV. Methods: This is an international, retrospective study including patients >18 years from 33 centres with transposition of the great arteries (TGA) following atrial switch operation and congenitally corrected TGA. The primary endpoint included overall survival and survival free from HF. The secondary endpoint was a composite of death, hospitalisation for HF, heart transplant, mechanical support and ventricular tachycardia/implantable cardioverter-defibrillator therapies. Results: We identified 105 out of 1721 patients (3.5%) who underwent CRT. Median follow-up after CRT implant was 4.6 (1.6–8) years. QRS improvement was limited to those with previous pacing (167±35 vs 154±28 ms; p=0.002). Following CRT, there was no significant change in B-type natriuretic peptide values, peak VO 2 and tricuspid regurgitation severity by echocardiography. CRT complications occurred in 10 (9.5%), though they were usually minor. Patients with CRT were propensity-matched to controls according to age, sex, anatomy, presence of complex disease, previous HF and sRV dysfunction at baseline. At univariable analysis, CRT (HR 4.39–95%, CI 1.6 to 11.9; p=0.003), older age and moderate-to-severe sRV dysfunction at baseline were predictive of death, while CRT (HR 3–95%, CI 1.3 to 7; p=0.01) and sRV dysfunction were associated with HF admission. By multivariable analysis, CRT (HR 8.8–95%, CI 2.9 to 26.6; p=0.0001) and age (HR 1.1%–95%, CI 1.01 to 1.15; p<0.0001) were independently associated with poorer outcome. Conclusion: In this retrospective study in the largest population thus far described with an sRV, CRT implant was not associated with improved survival, even after controlling for key confounders.
Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience
Background: Cardiac resynchronisation therapy (CRT) is a key treatment for heart failure (HF) in acquired heart disease, but its benefits in adults with congenital heart disease and a systemic right ventricle (sRV) remain unclear. This study aimed to assess whether CRT improves outcomes in patients with sRV. Methods: This is an international, retrospective study including patients >18 years from 33 centres with transposition of the great arteries (TGA) following atrial switch operation and congenitally corrected TGA. The primary endpoint included overall survival and survival free from HF. The secondary endpoint was a composite of death, hospitalisation for HF, heart transplant, mechanical support and ventricular tachycardia/implantable cardioverter-defibrillator therapies. Results: We identified 105 out of 1721 patients (3.5%) who underwent CRT. Median follow-up after CRT implant was 4.6 (1.6–8) years. QRS improvement was limited to those with previous pacing (167±35 vs 154±28 ms; p=0.002). Following CRT, there was no significant change in B-type natriuretic peptide values, peak VO 2 and tricuspid regurgitation severity by echocardiography. CRT complications occurred in 10 (9.5%), though they were usually minor. Patients with CRT were propensity-matched to controls according to age, sex, anatomy, presence of complex disease, previous HF and sRV dysfunction at baseline. At univariable analysis, CRT (HR 4.39–95%, CI 1.6 to 11.9; p=0.003), older age and moderate-to-severe sRV dysfunction at baseline were predictive of death, while CRT (HR 3–95%, CI 1.3 to 7; p=0.01) and sRV dysfunction were associated with HF admission. By multivariable analysis, CRT (HR 8.8–95%, CI 2.9 to 26.6; p=0.0001) and age (HR 1.1%–95%, CI 1.01 to 1.15; p<0.0001) were independently associated with poorer outcome. Conclusion: In this retrospective study in the largest population thus far described with an sRV, CRT implant was not associated with improved survival, even after controlling for key confounders.
- 2 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1536-1551
EMBRACE Study: Outcomes of a Randomized, Mindfulness-Based Intervention for Adults with Congenital Heart Disease
Adults with congenital heart disease (ACHD) have high rates of anxiety and depression. Strategies to manage the stress of having a chronic disease, improve coping skills and resilience can reduce these rates. To examine the effectiveness of an ACHD-specific, real-time virtual mindfulness-based behavioral intervention (MBBI) on mental health and resilience. A randomized wait-list control study was conducted, testing a virtual MBBI for 90 min once weekly × 6 weeks compared to standard of care (SOC) control. Primary outcomes of anxiety and depression were assessed through the Hospital and Anxiety and Depression Scale (HADS-A/HADS-D), while secondary outcomes of resilience and mindfulness were assessed through the Brief Resilience Scale (BRS) and Cognitive and Affective Mindfulness Scale-Revised (CAMS-R), respectively. Outcomes were assessed pre–post-intervention and 3-month post-intervention. Forty-one participants were recruited. Thirty-one participants (average age = 39.7 + 12.6 years, 64.5% female) completed the study, attending an average of 5 sessions. While the randomization groups did not show differences in changes in any outcomes, participants did show meaningful improvements after the EMBRACE intervention in anxiety [60.9% with decreased HADS-A (95% CI 43.8–76.8%)]; depression [48.4% with decreased HADS-D (95% CI 31.6–65.5%)]; resilience [43.6% with increased BRS score (95% CI 26.9–61.0%)]; and mindfulness [69.4% with increased CAMS-R-score (95% CI 52.3–84.0%)] scores. Satisfaction surveys revealed that 97% found the program effective. Major qualitative themes included community connections, focus on self-care and self-management. The EMBRACE study demonstrates the effectiveness of a virtual intervention to improve mental health, resilience, and coping skills. Further study is needed to evaluate the long-term benefits and sustainability for ACHD patients.
- 2 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1536-1551
EMBRACE Study: Outcomes of a Randomized, Mindfulness-Based Intervention for Adults with Congenital Heart Disease
Adults with congenital heart disease (ACHD) have high rates of anxiety and depression. Strategies to manage the stress of having a chronic disease, improve coping skills and resilience can reduce these rates. To examine the effectiveness of an ACHD-specific, real-time virtual mindfulness-based behavioral intervention (MBBI) on mental health and resilience. A randomized wait-list control study was conducted, testing a virtual MBBI for 90 min once weekly × 6 weeks compared to standard of care (SOC) control. Primary outcomes of anxiety and depression were assessed through the Hospital and Anxiety and Depression Scale (HADS-A/HADS-D), while secondary outcomes of resilience and mindfulness were assessed through the Brief Resilience Scale (BRS) and Cognitive and Affective Mindfulness Scale-Revised (CAMS-R), respectively. Outcomes were assessed pre–post-intervention and 3-month post-intervention. Forty-one participants were recruited. Thirty-one participants (average age = 39.7 + 12.6 years, 64.5% female) completed the study, attending an average of 5 sessions. While the randomization groups did not show differences in changes in any outcomes, participants did show meaningful improvements after the EMBRACE intervention in anxiety [60.9% with decreased HADS-A (95% CI 43.8–76.8%)]; depression [48.4% with decreased HADS-D (95% CI 31.6–65.5%)]; resilience [43.6% with increased BRS score (95% CI 26.9–61.0%)]; and mindfulness [69.4% with increased CAMS-R-score (95% CI 52.3–84.0%)] scores. Satisfaction surveys revealed that 97% found the program effective. Major qualitative themes included community connections, focus on self-care and self-management. The EMBRACE study demonstrates the effectiveness of a virtual intervention to improve mental health, resilience, and coping skills. Further study is needed to evaluate the long-term benefits and sustainability for ACHD patients.
- 25 June 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1408-1415
Supporting the Journey: A Scoping Review of Healthcare Transition Programs for Adolescents with Congenital Heart Disease
The growing adult CHD population has created a demand for formalized transition programs from pediatric to adult cardiac care. Despite global implementation, these programs vary widely in structure, and there is limited understanding of which elements best improve clinical outcomes and quality of life. This scoping review of the literature on healthcare transition programs for children and adolescents with CHD examined various program models, identified common key concepts, and highlighted gaps in the field, providing future directions for research and program development. A comprehensive search of PUBMED/Medline, Scopus, CINAHL, and Cochrane Library (2017–2023) identified English-language original research on CHD transition programs reporting qualitative or quantitative outcomes. Outcomes were grouped into themes: medical knowledge, self-management, and successful transfer. Ten studies met the inclusion criteria. All seven studies reporting medical knowledge outcomes found an increase in patients’ medical knowledge following program completion, though methods of measurement varied. Four studies reported successful transfer outcomes, while five demonstrated improvements in self-management skills. Several studies also included patient reported outcomes. While various healthcare transition models exist, each with distinct strengths and weaknesses, it is important to customize the program to the needs of the local CHD patient population and the institution providing care. Advancing care for this group requires increased resources, improved reimbursement models, stronger infrastructure, and comprehensive education and training to encourage institutions to develop programs that meet patient needs.
- 25 June 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1408-1415
Supporting the Journey: A Scoping Review of Healthcare Transition Programs for Adolescents with Congenital Heart Disease
The growing adult CHD population has created a demand for formalized transition programs from pediatric to adult cardiac care. Despite global implementation, these programs vary widely in structure, and there is limited understanding of which elements best improve clinical outcomes and quality of life. This scoping review of the literature on healthcare transition programs for children and adolescents with CHD examined various program models, identified common key concepts, and highlighted gaps in the field, providing future directions for research and program development. A comprehensive search of PUBMED/Medline, Scopus, CINAHL, and Cochrane Library (2017–2023) identified English-language original research on CHD transition programs reporting qualitative or quantitative outcomes. Outcomes were grouped into themes: medical knowledge, self-management, and successful transfer. Ten studies met the inclusion criteria. All seven studies reporting medical knowledge outcomes found an increase in patients’ medical knowledge following program completion, though methods of measurement varied. Four studies reported successful transfer outcomes, while five demonstrated improvements in self-management skills. Several studies also included patient reported outcomes. While various healthcare transition models exist, each with distinct strengths and weaknesses, it is important to customize the program to the needs of the local CHD patient population and the institution providing care. Advancing care for this group requires increased resources, improved reimbursement models, stronger infrastructure, and comprehensive education and training to encourage institutions to develop programs that meet patient needs.
- 9 November 2024
- Published by Elsevier in American Heart Journal
- Vol. 280, 30-41
Pregnancy care experiences for adults with congenital heart disease in the United States
- 9 November 2024
- Published by Elsevier in American Heart Journal
- Vol. 280, 30-41
Pregnancy care experiences for adults with congenital heart disease in the United States